Cancer-specific T cell receptor discovery using 150,000 clinical genomics samples
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Here, we identified public TCRs against therapeutically relevant targets via computational analysis of large-scale bulk RNA sequencing data obtained from routine clinical genomics testing.
Appeared: Friday, November 6. Science Translational Medicine. Peer-reviewed journal.